About this trial
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
Eligibility criteria
Qualifiers
Male or female, aged 18 years or older.
Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
Malignant tumor confirmed histologically or cytologically.
Disqualifiers
Pregnant or breastfeeding women.
Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
Trial design
Treatments tested in this trial
- No Interventions